TALTZ

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug TALTZ contains one active pharmaceutical ingredient (API):

1 Ixekizumab UNII BTY153760O - IXEKIZUMAB

Ixekizumab is an IgG4 monoclonal antibody that binds with high affinity (<3 pM) and specificity to interleukin 17A (both IL-17A and IL-17A/F). Elevated concentrations of IL-17A have been implicated in the pathogenesis of psoriasis by promoting keratinocyte proliferation and activation, as well as in the pathogenesis of psoriatic arthritis. Neutralisation of IL-17A by ixekizumab inhibits these actions. Read about Ixekizumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TALTZ Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AC13		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11032P, 11033Q, 11623R, 12209N, 12217B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507618030020801, 507618030020901, 507618030021001, 507618030021101, 507618030021201, 507618030021301
Country: CA	Health Products and Food Branch	Identifier(s): 02455102, 02455110
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 158-MBE-0620
Country: EE	Ravimiamet	Identifier(s): 1717073, 1717084, 1717095, 1717107, 1717118, 1717129
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151085001, 1151085004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 168388, 589343
Country: FR	Base de données publique des médicaments	Identifier(s): 60241034, 61077659
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 328137, 336899
Country: HK	Department of Health Drug Office	Identifier(s): 65209, 65211
Country: IE	Health Products Regulatory Authority	Identifier(s): 88600, 88737
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7985
Country: IT	Agenzia del Farmaco	Identifier(s): 044863013, 044863025, 044863037, 044863049, 044863052, 044863064
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999442G1023, 3999442G2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1080174, 1080175, 1080176, 1080177, 1080178, 1080179
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132039, 132047
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100370679
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67999001, W67999002, W67999003, W68000001, W68000002, W68000003
Country: SG	Health Sciences Authority	Identifier(s): 15501P
Country: US	FDA, National Drug Code	Identifier(s): 0002-1445, 0002-7724